"Company","Current Parent Company","Parent at the Time of the Penalty Announcement","Recap of Ownership Changes","City / Town","County","Nation / Region","Company Number","Penalty (in pounds)","Penalty Year","Penalty Date","Offence Group","Offence Type","Violation Description","Settlement Type","Case Number","Agency","HQ Country of Parent","Ownership Structure of Parent","Major Industry of Parent","Specific Industry of Parent","Parent company ISIN","Source of Data","Source Notes" "Pfizer Limited","Pfizer","Pfizer","","","","","","63,300,000","2022","20220721","competition-related offences","price-fixing or anti-competitive practices","Pfizer and Flynn were fined £63 million and £6.7 million respectively after a finding by the CMA that the companies illegally exploited their dominant market position to charge the NHS excessive prices for phenytoin sodium capsules, an anti-epilepsy medicine, with Pfizer stopping sale of its price regulated branded version and transferring the contract to Flynn who sold the same phenytoin as a generic price unregulated drug with over 1000% price increases.","","","Competition and Markets Authority","United States","publicly traded","pharmaceuticals","pharmaceuticals","US7170811035","https://www.gov.uk/government/news/70-million-in-fines-for-pharma-firms-that-overcharged-nhs",""